To Our Australian NRL Customers,

We are letting you know that pricing for Optitrol QC products has increased, effective 1 September 2026.

Our commitment to the quality, service, and support you've come to expect from NRL remains unchanged. We value your loyalty, and we're always open to discussing service contracts or pricing arrangements that work for your organisation.

Any existing pricing agreements remain in place unless we've advised you otherwise.

If you have any questions or feedback, please reach out to our Customer Relations & Marketing Manager, Dhru Xiros, at dhru@nrlquality.org.au.

Hit the link to review our latest EDCNet Investigations PMM-QC-2591 and PMM-QC-3004

We are writing to provide an important recommendation for laboratories transitioning to the Abbott Anti-HCV NEXT assay.

If you are planning to move, or have recently moved, to the Abbott Anti-HCV NEXT assay, we strongly recommend updating your quality control materials accordingly:

Recommended control: Optitrol Yellow
Previous control (for prior assay): Optitrol Blue
This recommendation ensures your QC program remains optimally matched to the performance characteristics of the Abbott Anti-HCV NEXT assay.

If you have any questions about this transition or would like further guidance, please don't hesitate to contact the NRL team below or at qconnect@nrlquality.org.au